Walleye Capital
IBB icon

Walleye Capital’s iShares Biotechnology ETF IBB Stock Holding History

Walleye Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,097
Closed -$2.55M – 4656
2025
Q4 		$2.55M Buy
+15,097
New +$2.45M 0.01% 1676
2025
Q3 		– Sell
-4,655
Closed -$589K – 4784
2025
Q2 		$589K Buy
4,655
+985
+27% +$121K ﹤0.01% 2497
2025
Q1 		$469K Sell
3,670
-4,588
-56% -$622K ﹤0.01% 2617
2024
Q4 		$1.09M Sell
8,258
-760
-8% -$107K ﹤0.01% 2308
2024
Q3 		$1.31M Buy
9,018
+4,082
+83% +$591K ﹤0.01% 2355
2024
Q2 		$678K Sell
4,936
-4,064
-45% -$543K ﹤0.01% 3227
2024
Q1 		$1.23M Buy
9,000
+6,301
+233% +$861K ﹤0.01% 2387
2023
Q4 		$367K Buy
+2,699
New +$329K ﹤0.01% 3196

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Capital's IBB Position: Q1 2026 in Review

Walleye Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 15,097 shares — an estimated $2.55M sold.

Walleye Capital first reported a position in IBB in Q4 2023 and held it in 8 quarters. The position peaked at $2.55M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Walleye Capital reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 15,097 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.55M.
  • Walleye Capital first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 8 quarters.
  • Walleye Capital's iShares Biotechnology ETF position peaked at $2.55M in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.